SVLSF IV, LLC Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for SVLSF IV, LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of SVLSF IV, LLC. SVLSF IV, LLC is 10% Owner in KalVista Pharmaceuticals, Inc. ($CBYL) and 10% Owner in ENTELLUS MEDICAL INC ($ENTL) and 10% Owner in OCULAR THERAPEUTIX, INC ($OCUL) and 10% Owner in NeurogesX Inc ($NGSX).

Latest Insider Trading Transactions of SVLSF IV, LLC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ENTL, KALV, NGSX, OCUL

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 10 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS29.4037410,99447,47147.8 K to 47.5 K (-0.78 %)
Apr 10 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS29.4013,157386,7531,672,1051.7 M to 1.7 M (-0.78 %)
Apr 10 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS28.5337710,75647,84548.2 K to 47.8 K (-0.78 %)
Apr 10 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS28.5313,292379,2271,685,2621.7 M to 1.7 M (-0.78 %)
Apr 10 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS29.4962918,55048,22248.9 K to 48.2 K (-1.29 %)
Apr 10 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS29.4922,171653,8651,698,5541.7 M to 1.7 M (-1.29 %)
Apr 02 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS28.762537,27748,85149.1 K to 48.9 K (-0.52 %)
Apr 02 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS28.768,888255,6531,720,7251.7 M to 1.7 M (-0.51 %)
Apr 02 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS27.661,45840,32649,10450.6 K to 49.1 K (-2.88 %)
Apr 02 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS27.6651,3731,420,8851,729,6131.8 M to 1.7 M (-2.88 %)
Apr 02 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS28.4096927,51650,56251.5 K to 50.6 K (-1.88 %)
Apr 02 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS28.4034,133969,2411,780,9861.8 M to 1.8 M (-1.88 %)
Mar 28 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS27.801,01228,13551,53152.5 K to 51.5 K (-1.93 %)
Mar 28 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS27.8035,653991,1891,815,1191.9 M to 1.8 M (-1.93 %)
Mar 28 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS29.061,59946,46652,54354.1 K to 52.5 K (-2.95 %)
Mar 28 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS29.0656,3181,636,5561,850,7721.9 M to 1.9 M (-2.95 %)
Mar 28 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS29.7083124,67954,14255 K to 54.1 K (-1.51 %)
Mar 28 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS29.7029,262869,0081,907,0901.9 M to 1.9 M (-1.51 %)
Mar 20 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS26.707,246193,46854,97362.2 K to 55 K (-11.65 %)
Mar 20 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS26.70255,2246,814,4811,936,3522.2 M to 1.9 M (-11.65 %)
Mar 06 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS23.0489320,57262,21963.1 K to 62.2 K (-1.41 %)
Mar 06 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS23.0431,439724,2452,191,5762.2 M to 2.2 M (-1.41 %)
Mar 06 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS22.911,19727,42063,11264.3 K to 63.1 K (-1.86 %)
Mar 06 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS22.9142,181966,2402,223,0152.3 M to 2.2 M (-1.86 %)
Feb 21 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS20.604,76498,13864,30969.1 K to 64.3 K (-6.90 %)
Feb 21 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS20.60167,7793,456,2472,265,1962.4 M to 2.3 M (-6.90 %)
Feb 21 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS20.0264112,83069,07369.7 K to 69.1 K (-0.92 %)
Feb 21 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS20.0222,594452,2392,432,9752.5 M to 2.4 M (-0.92 %)
Feb 21 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS20.7350810,53269,71470.2 K to 69.7 K (-0.72 %)
Feb 21 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS20.7317,912371,3662,455,5692.5 M to 2.5 M (-0.72 %)
Jan 07 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS20.41721,47070,22270.3 K to 70.2 K (-0.10 %)
Jan 07 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS20.412,52751,5812,473,4812.5 M to 2.5 M (-0.10 %)
Jan 07 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS20.014794170,29470.3 K to 70.3 K (-0.07 %)
Jan 07 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS20.011,65333,0812,476,0082.5 M to 2.5 M (-0.07 %)
Jan 02 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS20.00612070,34170.3 K to 70.3 K (-0.01 %)
Jan 02 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS20.001943,8802,477,6612.5 M to 2.5 M (-0.01 %)
Jan 02 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS20.0070214,04370,34771 K to 70.3 K (-0.99 %)
Jan 02 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS20.0024,716494,4192,477,8552.5 M to 2.5 M (-0.99 %)
Jan 02 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS20.031032,06371,04971.2 K to 71 K (-0.14 %)
Jan 02 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS20.033,63172,7182,502,5712.5 M to 2.5 M (-0.14 %)
Dec 21 2018KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS20.02591,18171,15271.2 K to 71.2 K (-0.08 %)
Dec 21 2018KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS20.022,07741,5772,506,2022.5 M to 2.5 M (-0.08 %)
Feb 02 2017ENTLENTELLUS MEDICAL I ...SVLSF IV, LLC10% OwnerSellS17.008,501144,51750,84959.4 K to 50.8 K (-14.32 %)
Feb 02 2017ENTLENTELLUS MEDICAL I ...SVLSF IV, LLC10% OwnerSellS17.00299,4245,090,2081,791,0702.1 M to 1.8 M (-14.32 %)
Feb 02 2017ENTLENTELLUS MEDICAL I ...SVLSF IV, LLC10% OwnerSellS17.002,10635,80210,42412.5 K to 10.4 K (-16.81 %)
Feb 02 2017ENTLENTELLUS MEDICAL I ...SVLSF IV, LLC10% OwnerSellS17.002,61544,45512,94715.6 K to 12.9 K (-16.80 %)
Feb 02 2017ENTLENTELLUS MEDICAL I ...SVLSF IV, LLC10% OwnerSellS17.00220,4313,747,3271,091,1661.3 M to 1.1 M (-16.81 %)
Nov 25 2016CBYLKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerGrantA0.0071,211071,2110 to 71.2 K
Nov 25 2016CBYLKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerGrantA0.002,508,27902,508,2790 to 2.5 M
Jun 11 2015OCULOCULAR THERAPEUTIX ...SVLSF IV, LLC10% OwnerSellS22.0010,297226,53461,08471.4 K to 61.1 K (-14.43 %)
Jun 11 2015OCULOCULAR THERAPEUTIX ...SVLSF IV, LLC10% OwnerSellS22.00362,7037,979,4662,151,5232.5 M to 2.2 M (-14.43 %)
Jun 11 2015OCULOCULAR THERAPEUTIX ...SVLSF IV, LLC10% OwnerSellS22.00373,0008,206,0002,212,6072.6 M to 2.2 M (-14.43 %)
Jun 11 2015OCULOCULAR THERAPEUTIX ...SVLSF IV, LLC10% OwnerSellS22.00373,0008,206,0002,212,6072.6 M to 2.2 M (-14.43 %)
May 05 2010NGSXNeurogesX IncSVLSF IV, LLC10% OwnerSellS10.258,28284,89161,32469.6 K to 61.3 K (-11.90 %)
May 05 2010NGSXNeurogesX IncSVLSF IV, LLC10% OwnerSellS10.25291,7182,990,1102,159,9912.5 M to 2.2 M (-11.90 %)

Page:   1